Past Podcast Episodes

The National MS Society has updated their COVID-19 vaccine guidance for people living with MS, providing detailed recommendations for timing your disease-modifying therapy with the two COVID-19 vaccines that are approved in the U.S. If you're on a disease-modifying therapy and you've been wondering about your DMT and the COVID-19 vaccines, this episode is for you.

My guest this week is Dr. Jaime Imitola, the Director of the Division of Multiple Sclerosis and Translational Neuroimmunology at UConn Health, a noted expert in his field, and a member of the task force that the MS Society convened to create the COVID-19 vaccine guidance.

We're talking about the new updates to the vaccine guidance, answering some of the questions that you've sent my way, and we'll get into how this task force went about creating this very important guidance for people living with MS.

We're also talking about the FDA approval of intramuscular injections for Plegridy (and how that came about!)

We'll tell you about BRAINTEASER, a European Union initiative that will leverage artificial intelligence in an effort to treat people living with ALS and MS by providing predictive care instead of reactive care.

And we'll explain how the newly announced Gladstone-UCSF Center for Neurovascular Brain Immunology is opening a new front in the war on MS.

We have a lot to talk about! Are you ready for RealTalk MS??!

Facts are facts, right? :22

National MS Society issues guidance for timing MS medications and COVID-19 mRNA vaccines 4:35

The latest reason to download the RealTalk MS app 5:26

FDA approves Intramuscular injection for Plegridy 6:15

BRAINTEASER launches 7:24

The Gladstone-UCSF Center for Neurovascular Brain Immunology 9:55

My interview with Dr. Jaime Imitola 12:26

Share this episode 28:12

WalkMS 2021 is here! 28:32

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/180

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society COVID-19 Vaccine Guidance for People Living with MS

National MS Society: Timing MS Medications with COVID-19 mRNA Vaccines

WalkMS 2021

Join the RealTalk MS Facebook Group

Download the RealTalk MS App for iOS

Download the RealTalk MS App for Android

Give RealTalk MS a Rating and Review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 180
Guests: Dr. Jaime Imitola

Tags: MS, MultipleSclerosis, MSResearch, MSSociety, COVID19, RealTalkMS

Privacy Policy

Research has shown that, for people living with MS, regular exercise and physical activity can improve their quality of life while helping to manage MS symptoms.

But research has also shown that people living with MS tend to be less active than people in the general population. In response, the National MS Society convened a group of experts to develop fact-based guidance for promoting exercise and lifestyle physical activity for all people with MS, regardless of their ability level.

Joining me to talk about these exercise recommendations along with some of the real benefits that exercise produces for people living with MS is Dr. Nora Fritz, a board-certified Neurologic Physical Therapist and an Assistant Professor in the Physical Therapy Program in the Department of Health Care Sciences and Department of Neurology at Wayne State University School of Medicine, where she's also the Director of the Neuroimaging and Neurorehabilitation Laboratory.

Judy Boon was diagnosed with MS in 2007. Judy is a true MS Warrior who has fully integrated fitness activities and exercise into her everyday lifestyle. Judy is also joining me to talk about how exercise has impacted her MS journey.

We're also talking about a University of Washington study that measured the willingness to receive a COVID-19 vaccine among people living with MS.

We'll tell you about a study from Italy that measured the long-term benefits of autologous hematopoietic stem cell transplantation (aHSCT).

And we're talking about an important survey that measured the perspectives and preferences regarding MS research among racial and ethnic groups.

We have a lot to talk about! Are you ready for RealTalk MS??!

Study measures COVID-19 vaccine willingness among people living with MS 2:23

Study shows long-term benefits of analogous Hematopoietic Stem Cell Transplantation 6:32

Study measures perspectives and preferences for MS research among racial and ethnic groups 9:15

Study shows a cancer treatment may protect the blood-brain barrier and reduce neuroinflammation 9:05

My interview with Dr. Nora Fritz 12:45

My interview with Judy Boone 25:14

Share this episode 34:47

Walk MS 2021 is coming! 35:07

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/179

ADD YOUR VOICE TO THE CONVERSATION

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Give RealTalk MS a Rating and Review

National MS Society COVID-19 Vaccine Guidance for People Living with MS

What You Need to Know About Coronavirus (COVID-19)

RealTalk MS Episode 177: Dr. Nancy Sicotte Answers Your Questions about the COVID-19 Vaccine and MS

STUDY: Willingness to Obtain COVID-19 Vaccination in Adults with Multiple Sclerosis in the United States

STUDY: Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis

Autologous Hematopoietic Stem Cell Transplant in Multiple Sclerosis: Recommendations of the National Multiple Sclerosis Society

STUDY: Perceptions and Preferences Regarding Multiple Sclerosis Research Among Racial and Ethnic Groups

iConquerMS

Walk MS 2021

National MS Society COVID-19 Response Fund

Join the RealTalk MS Facebook Group